LAUREL SOCKRIDER: Open Payments
NPI 1881132314 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 49 payments from 15 companies in 2025. Trend: 2023 $222 · 2024 $1,114 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $243 |
| AstraZeneca Pharmaceuticals LP | 9 | $179 |
| Otsuka America Pharmaceutical, Inc. | 7 | $137 |
| Aimmune Therapeutics, Inc. | 4 | $99 |
| Lundbeck LLC | 4 | $76 |
| Lilly USA, LLC | 4 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Abbott Laboratories | 2 | $51 |
| ABBVIE INC. | 2 | $46 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
Products named: REXULTI, Ozempic, ZENPEP, AIRSUPRA, CAPLYTA, BREZTRI, Rybelsus, AVEIR.
Industry payments across AZ — which companies pay providers there.
